RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase
about
Response gene to complement 32 interacts with Smad3 to promote epithelial-mesenchymal transition of human renal tubular cellsRGC-32 mediates transforming growth factor-beta-induced epithelial-mesenchymal transition in human renal proximal tubular cellsResponse gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cellsResponse gene to complement 32, a novel hypoxia-regulated angiogenic inhibitorRGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrestOntological visualization of protein-protein interactionsMembrane attack by complement: the assembly and biology of terminal complement complexesLuteinizing hormone-induced RUNX1 regulates the expression of genes in granulosa cells of rat periovulatory folliclesResponse gene to complement 32 is essential for fibroblast activation in renal fibrosisResponse gene to complement 32 regulates the G2/M phase checkpoint during renal tubular epithelial cell repair.RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries.Responses of cultured human keratocytes and myofibroblasts to ethyl pyruvate: a microarray analysis of gene expressionResponse gene to complement 32 protein promotes macrophage phagocytosis via activation of protein kinase C pathway.Upregulation of the cell-cycle regulator RGC-32 in Epstein-Barr virus-immortalized cells.Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration.The role of complement in tumor growthWilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neckMetabolism and regulation of gene expression by 4-oxoretinol versus all-trans retinoic acid in normal human mammary epithelial cells.Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3Gene expression of rat alveolar type II cells during hyperoxia exposure and early recoveryAstrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesionsRNA sequencing for global gene expression associated with muscle growth in a single male modern broiler line compared to a foundational Barred Plymouth Rock chicken lineResponse gene to complement 32 (RGC-32) expression on M2-polarized and tumor-associated macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4.Response gene to complement 32 expression is induced by the luteinizing hormone (LH) surge and regulated by LH-induced mediators in the rodent ovaryPromoter Methylation and mRNA Expression of Response Gene to Complement 32 in Breast CarcinomaRGC-32 is a novel regulator of the T-lymphocyte cell cycleRole of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.Innate immunity as orchestrator of bone marrow homing for hematopoietic stem/progenitor cells.Complement inhibition in cancer therapy.Role of SIRT1 in autoimmune demyelination and neurodegeneration.The role of complement activation in atherogenesis: the first 40 years.The role of complement system in adipose tissue-related inflammation.Knockdown of response gene to complement 32 (RGC32) induces apoptosis and inhibits cell growth, migration, and invasion in human lung cancer cells.Overexpression of response gene to complement 32 (RGC32) promotes cell invasion and induces epithelial-mesenchymal transition in lung cancer cells via the NF-κB signaling pathway.Epigenetic modifications induced by RGC-32 in colon cancer.Response gene to complement 32, a novel regulator for transforming growth factor-beta-induced smooth muscle differentiation of neural crest cells.The expression of response gene to complement 32 on renal ischemia reperfusion injury in rat.Hypoxia-inducible factor 1α participates in hypoxia-induced epithelial-mesenchymal transition via response gene to complement 32Regulator of Cell Cycle (RGCC) Expression During the Progression of Alzheimer's Disease.Pumilio directs deadenylation-associated translational repression of the cyclin-dependent kinase 1 activator RGC-32.
P2860
2467770e51824f9ba7ec35fbcbd8aab77eb22da824b52ca57b8f5264ea3aefcd5c60e5eeb7beef0d3a9aa2a14c08f53569fc81a8721f75368b169379549c5831e57190ec627159ecf9413d51a86a45cbc2915bc5bf0ab899dfe1fa236a7f7f38c41813e7d018ba374700f75e62e390810fe54dd488e8f81be47e1eb32f6ddfd3ce07e273178d7f8acda7bde9f6a4054812b5a55cdc3c68304a97aa80db9c748efe936cf70ea42833eb159d5b5915f849ffc391ad
P248
Q24292825-11F3DBF8-7395-4CEA-AA75-3E2D3E46BE6CQ24318927-FA3E75C5-072F-4DDC-993E-1752908BBE29Q24319998-BBBA7113-40DC-4370-8F28-514AF8D911E9Q24320745-364080B2-A600-41E8-926C-EF95A9C9AE7CQ24322861-4CEB632B-0044-428E-9900-9E2A2771BEDBQ24795348-3618F3D2-331E-4100-AD6F-EFB94DC22DE0Q26997385-70CAA3D9-F813-49CC-90B9-2685CF92C7C7Q28577462-1DF03F1F-1620-406B-9CC3-A236AF54CC08Q28588339-DCE13319-0370-4657-9544-B205081B8823Q33634561-D1014FF2-8D3F-4898-B036-42FBFDBA31E5Q33780229-760243E2-447B-48D9-9A3C-297D413E8726Q33938175-C7006D07-E122-4A76-8800-7CB658BBFEC5Q34044591-3EF569B1-16BF-4A7E-BDDD-17DC8F116DBAQ34097970-64F6740F-1954-4C17-930E-C655E0AA250AQ35135052-C50A2529-6520-447A-9741-DA5733F70062Q35231345-10A8CF9E-7072-4601-8CB3-0FA28B9F0034Q35575285-3B8CD8C0-D104-4652-A769-485568BDFCF6Q35860799-17455DA0-39E6-46DB-85B3-3DA0C3C1B1C2Q35914358-00A129CE-C4AD-4FBF-8D5B-CC4CF926037BQ36137324-BCFA073B-B09D-4793-9E6D-2EB23D609860Q36186755-A2D2171B-4EEE-4D88-9CEF-9E0B40597909Q36249231-31ECFD42-3795-47BC-BE22-E07084AF9DD7Q36473183-1EB876C6-AE8E-4A67-9807-2A3646EC7379Q36692147-E62C75C1-C8B6-44EE-8803-D4CDF4D99880Q36789487-CA132292-10EB-4597-B2DB-8020548A2C9CQ37334611-D1BFC33C-90AB-4B65-B99E-923D47268280Q38068141-9511E72E-600E-4745-ACEA-5BE0189C62B7Q38080873-C742E51B-9870-41BA-A031-4702B6B87BDCQ38109340-0230FD3B-8867-4434-9C9E-FAE5F02BF2E6Q38256576-827464F8-B229-4059-B1E0-78E75C70C1DDQ38532361-8F23EB89-E618-49CD-8FDE-BD704A046269Q38692815-8254DBDA-7A12-4FE7-AEB2-41F7CAC9E68CQ38994477-A52B076A-96AE-4671-B150-D54A8C6F1F01Q39146438-D4A9E5CA-FBD5-4E77-A7F3-4D56177D2C37Q39780293-2CFEF123-8907-4924-93C5-9D4B62175109Q40165786-3EAAAABE-0D2C-4786-BF06-29893A3E7091Q40227380-5DF0F307-FFE1-4412-B556-413E0457A9A8Q41116454-189F3780-795B-4399-8F32-8AB404E7C615Q43266310-5616BFA6-FBCE-4661-95A0-F43DD4E634DFQ47547593-31E6A99D-FAC1-4801-961C-A796A72E2A0C
P2860
RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@ast
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@en
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@en-gb
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@nl
type
label
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@ast
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@en
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@en-gb
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@nl
prefLabel
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@ast
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@en
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@en-gb
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@nl
P2093
P2860
P921
P3181
P356
P1476
RGC-32 increases p34CDC2 kinas ...... ooth muscle cells into S-phase
@en
P2093
Florin Niculescu
Hila Sorana
Lucian Soane
Matthew Fosbrink
Moon L Shin
Violeta Rus
P2860
P304
P3181
P356
10.1074/JBC.M109354200
P407
P577
2001-10-30T00:00:00Z